Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Tara C. Gangadhar, MD

Tara C. Gangadhar, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Gangadhar is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Medicine
    • Medical Oncology

Programs & Centers:

  • Cancer
    • Melanoma and Pigmented Lesion Program
  • LGBT Health

Board Certification:

  • Internal Medicine, 2007
  • Medical Oncology, 2010

Clinical Expertise:

  • Melanoma
  • Skin Cancer

Description of Clinical Expertise

Melanoma
Cutaneous malignancies
Gastroinitestinal malignancies

Practice Locations and Appointments

  • Melanoma and Pigmented Lesions

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: New York University School of Medicine
Residency: Indiana University Hospital
Fellowship: University of Chicago Medical Center

Memberships

Abramson Cancer Center of the University of Pennsylvania, National American Society of Clinical Oncology, National American Society of Clinical Pharmacology and Therapeutics, National Melanoma Research Foundation Breakthrough Consortium, National Penn Institute for Immunolology, Local Society for Melanoma Research, International

Hospital Affiliation

Dr. Gangadhar is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Melanoma
Immune therpay
Targeted therapy
Phase I trials
Combination therapy
Experimental therapeutics
Pharmacology

Selected Publications:

Sholl Lynette M, Andea Aleodor, Bridge Julia A, Cheng Liang, Davies Michael A, Ehteshami Mani, Gangadhar Tara C, Kamel-Reid Suzanne, Lazar Alexander, Raparia Kirtee, Siroy Alan, Watson Kimberly L: Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Archives of pathology & laboratory medicine : 2015.

Ribas Antoni, Puzanov Igor, Dummer Reinhard, Schadendorf Dirk, Hamid Omid, Robert Caroline, Hodi F Stephen, Schachter Jacob, Pavlick Anna C, Lewis Karl D, Cranmer Lee D, Blank Christian U, O'Day Steven J, Ascierto Paolo A, Salama April K S, Margolin Kim A, Loquai Carmen, Eigentler Thomas K, Gangadhar Tara C, Carlino Matteo S, Agarwala Sanjiv S, Moschos Stergios J, Sosman Jeffrey A, Goldinger Simone M, Shapira-Frommer Ronnie, Gonzalez Rene, Kirkwood John M, Wolchok Jedd D, Eggermont Alexander, Li Xiaoyun Nic: Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. The Lancet. Oncology 16 (8): 908-18,2015.

Gangadhar Tara C, Schuchter Lynn M: Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status. JAMA oncology 1 (4): 427-8,2015.

Robert Caroline, Schachter Jacob, Long Georgina V, Arance Ana, Grob Jean Jacques, Mortier Laurent, Daud Adil, Carlino Matteo S, McNeil Catriona, Lotem Michal, Larkin James, Lorigan Paul, Neyns Bart, Blank Christian U, Hamid Omid, Mateus Christine, Shapira-Frommer Ronnie, Kosh Michele, Zhou Honghong, Ibrahim Nageatte, Ebbinghaus Scot, Ribas Antoni: Pembrolizumab versus Ipilimumab in Advanced Melanoma. The New England journal of medicine 372 (26): 2521-32,2015.

Twyman-Saint Victor Christina, Rech Andrew J, Maity Amit, Rengan Ramesh, Pauken Kristen E, Stelekati Erietta, Benci Joseph L, Xu Bihui, Dada Hannah, Odorizzi Pamela M, Herati Ramin S, Mansfield Kathleen D, Patsch Dana, Amaravadi Ravi K, Schuchter Lynn M, Ishwaran Hemant, Mick Rosemarie, Pryma Daniel A, Xu Xiaowei, Feldman Michael D, Gangadhar Tara C, Hahn Stephen M, Wherry E John, Vonderheide Robert H, Minn Andy J: Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520 (7547): 373-7,2015.

Wang Tao, Xiao Min, Ge Yingbin, Krepler Clemens, Belser Eric, Lopez-Coral Alfonso, Xu Xiaowei, Zhang Gao, Azuma Rikka, Liu Qin, Liu Rui, Li Ling, Amaravadi Ravi K, Xu Wei, Karakousis Giorgos, Gangadhar Tara C, Schuchter Lynn M, Lieu Melissa, Khare Sanika, Halloran Molly B, Herlyn Meenhard, Kaufman Russel E: BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth. Clinical cancer research : an official journal of the American Association for Cancer Research 21 (7): 1652-64,2015.

Gangadhar Tara C, Salama April Ks: Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types. OncoTargets and therapy 8 : 929-37,2015.

Robert Caroline, Ribas Antoni, Wolchok Jedd D, Hodi F Stephen, Hamid Omid, Kefford Richard, Weber Jeffrey S, Joshua Anthony M, Hwu Wen-Jen, Gangadhar Tara C, Patnaik Amita, Dronca Roxana, Zarour Hassane, Joseph Richard W, Boasberg Peter, Chmielowski Bartosz, Mateus Christine, Postow Michael A, Gergich Kevin, Elassaiss-Schaap Jeroen, Li Xiaoyun Nicole, Iannone Robert, Ebbinghaus Scot W, Kang S Peter, Daud Adil: Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet 384 (9948): 1109-17,2014.

Braunstein Inbal, Gangadhar Tara C, Elenitsas Rosalie, Chu Emily Y: Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption. Journal of Cutaneous Pathology : 2014.

Gangadhar Tara C, Vonderheide Robert H: Mitigating the toxic effects of anticancer immunotherapy. Nature Reviews Clinical Oncology 11 (2): 91-9,2014.

View all publications

Academic Contact Info

3400 Civic Center Blvd.
South Pavilion, 7th Floor

Philadelphia, PA 19104
Phone: (215) 662-7907
Fax: (215) 662-4646
Patient appointments: 800-789-PENN (7366)